Comment on Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer

被引：0
|
作者：
Tang, Yubo [1 ]
Wa, Qingde [2 ]
Huang, Shuai [3 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pharm, Guangzhou, Peoples R China
[2] Zunyi Med Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Intersect Xinpu Ave & Xinlong Avenue, Zunyi 563000, Peoples R China
[3] Guangzhou Med Univ, Dept Orthopaed Surg, Affiliated Hosp 2, 250 Changgang East Rd, Guangzhou 510260, Peoples R China
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 12期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1001/jamaoncol.2024.4581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1731 / 1731
页数：1
相关论文
共 50 条
  • [21] Adverse events associated with androgen receptor signaling inhibitors in the treatment of prostate cancer: A systematic review and network meta-analysis
    Cao, Brent
    Kim, Melissa
    Reizine, Natalie Marie
    Moreira, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 317 - 317
  • [22] Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-analysis
    Cao, Brent
    Kim, Melissa
    Reizine, Natalie M.
    Moreira, Daniel M.
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (03): : 237 - 250
  • [23] ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling
    Liu, Chengfei
    Armstrong, Cameron M.
    Ning, Shu
    Yang, Joy C.
    Lou, Wei
    Lombard, Alan P.
    Zhao, Jinge
    Wu, Chun-Yi
    Yu, Aiming
    Evans, Christopher P.
    Tepper, Clifford G.
    Li, Pui-kai
    Gao, Allen C.
    ONCOGENE, 2021, 40 (35) : 5379 - 5392
  • [24] ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling
    Chengfei Liu
    Cameron M. Armstrong
    Shu Ning
    Joy C. Yang
    Wei Lou
    Alan P. Lombard
    Jinge Zhao
    Chun-Yi Wu
    Aiming Yu
    Christopher P. Evans
    Clifford G. Tepper
    Pui-kai Li
    Allen C. Gao
    Oncogene, 2021, 40 : 5379 - 5392
  • [25] EVALUATION OF CARDIOVASCULAR EVENTS AMONG MEN WITH PROSTATE CANCER TREATED WITH ANDROGEN RECEPTOR SIGNALING INHIBITORS: A SYSTEMATIC REVIEW, META-ANALYSIS, AND NETWORK META-ANALYSIS
    Matsukawa, Akihiro
    Yanagisawa, Takafumi
    Rajwa, Pawel
    Parizi, Mehdi Kardoust
    Laukhtina, Ekaterina
    Klemm, Jakob
    Chiujdea, Sever
    Fazekas, Tamas
    Mori, Keiichiro
    Kimura, Shoji
    Miki, Jun
    Kimura, Takahiro
    Shariat, Shahrokh F.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1001 - E1001
  • [26] Evaluation of cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: A systematic review, meta-analysis, and network meta-analysis
    Matsukawa, A.
    Yanagisawa, T.
    Rajwa, P.
    Bekku, K.
    Kardoust, Mehdi P.
    Laukhtina, E.
    Klemm, J.
    Chiujdea, S.
    Fazekas, T.
    Mori, K.
    Kimura, S.
    Miki, J.
    Kimura, T.
    Shariat, S.
    EUROPEAN UROLOGY, 2024, 85 : S1574 - S1575
  • [27] Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review
    Yanagisawa, Takafumi
    Rajwa, Pawel
    Quhal, Fahad
    Kawada, Tatsushi
    Bekku, Kensuke
    Laukhtina, Ekaterina
    von Deimling, Markus
    Chlosta, Marcin
    Karakiewicz, Pierre I.
    Kimura, Takahiro
    Shariat, Shahrokh F.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [28] Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries
    Goto, Yusuke
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (06) : 597 - 598
  • [29] Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
    Jacob, Aasems
    Raj, Rishi
    Allison, Derek B.
    Myint, Zin W.
    CANCERS, 2021, 13 (21)
  • [30] Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
    Jillson, Lauren K.
    Yette, Gabriel A.
    Laajala, Teemu D.
    Tilley, Wayne D.
    Costello, James C.
    Cramer, Scott D.
    CANCERS, 2021, 13 (13)
12345